Targeting of PI3K-a and CDK4/6 kinases in mantle cell lymphomas with dual kinase inhibitor ON 123300-lactate

被引：0
|
作者：
Akula, Balireddy [1 ]
Divakar, Saikrishna A. [2 ]
Bharathi, Vijaya E. [2 ]
Mallireddigari, Muralidhar R. [1 ]
Subbaiah, D. R. C. Venkata [2 ]
Pallela, Venkat R. [1 ]
Billa, Vinay K. [2 ]
Cosenza, Stephen C. [2 ]
Reddy, E. Premkumar [2 ]
Reddy, M. V. Ramana [2 ]
机构：
[1] Onconova Therapeut Inc, Dept Med Chem, Newtown, PA 18940 USA
[2] Icahn Sch Med Mt Sinai, Dept Med Chem, New York, NY 10029 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2014年 / 248卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
493-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Dual Inhibition of CDK4/6 and PI3K/AKT/mTOR Signaling Impairs Energy Metabolism in MPM Cancer Cells
    Bonelli, Mara
    Terenziani, Rita
    Zoppi, Silvia
    Fumarola, Claudia
    La Monica, Silvia
    Cretella, Daniele
    Alfieri, Roberta
    Cavazzoni, Andrea
    Digiacomo, Graziana
    Galetti, Maricla
    Petronini, Pier Giorgio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (14) : 1 - 16
  • [42] A phase Ib study targeting PIM1 and CDK4/6 kinases in metastatic renal cell carcinoma (PICKRCC)
    Holder, Sheldon L.
    Warrick, Joshua
    Zhu, Junjia
    Drabick, Joseph J.
    Joshi, Monika
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [43] Targeting resistance to current CDK4/6 therapies by RGT-419B, an inhibitor with optimized kinase activity spectrum
    Xie, Zhi
    Han, Jing
    Hu, Zhilong
    He, Hu
    Sun, Xianqiang
    Zhang, Fei
    Lin, Jing
    Yao, Lili
    Wang, Xinjuan
    Mei, Liufeng
    Liu, Yangyang
    Zhu, Guoyun
    Chen, Xi
    Zhu, Xiaotian
    Zhong, Wenge
    CANCER RESEARCH, 2021, 81 (04)
  • [44] Targeting the CDK4/6-Rb Pathway Enhances Response to PI3K Inhibition in PIK3CA-Mutant Lung Squamous Cell Carcinoma
    Shi, Ruoshi
    Li, Ming
    Raghavan, Vibha
    Tam, Shirley
    Cabanero, Michael
    Pham, Nhu-An
    Shepherd, Frances A.
    Moghal, Nadeem
    Tsao, Ming-Sound
    CLINICAL CANCER RESEARCH, 2018, 24 (23) : 5990 - 6000
  • [45] Therapeutic Targeting of the Cyclin D3:CDK4/6 Complex in T Cell Leukemia
    Sawai, Catherine M.
    Freund, Jacquelyn
    Oh, Philmo
    Ndiaye-Lobry, Delphine
    Bretz, Jamieson C.
    Strikoudis, Alexandros
    Genesca, Lali
    Trimarchi, Thomas
    Kelliher, Michelle A.
    Clark, Marcus
    Soulier, Jean
    Chen-Kiang, Selina
    Aifantis, Iannis
    CANCER CELL, 2012, 22 (04) : 452 - 465
  • [46] PI3K inhibitor idelalisib enhances the anti-tumor effects of CDK4/6 inhibitor palbociclib via PLK1 in B-cell lymphoma
    Hu, Dingyao
    Cao, Jiaowu
    Yu, Hui
    Ding, Ning
    Mi, Lan
    Ye, Yingying
    Li, Miaomiao
    Wang, Dedao
    Wu, Jiajin
    Wang, Xiaogan
    Song, Yuqin
    Zhu, Jun
    Ping, Lingyan
    CANCER LETTERS, 2024, 597
  • [47] Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma
    Qie, Shuo
    Yoshida, Akihiro
    Parnham, Stuart
    Oleinik, Natalia
    Beeson, Gyda C.
    Beeson, Craig C.
    Ogretmen, Besim
    Bass, Adam J.
    Wong, Kwok-Kin
    Rustgi, Anil K.
    Diehl, J. Alan
    NATURE COMMUNICATIONS, 2019, 10
  • [48] Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma
    Shuo Qie
    Akihiro Yoshida
    Stuart Parnham
    Natalia Oleinik
    Gyda C. Beeson
    Craig C. Beeson
    Besim Ogretmen
    Adam J. Bass
    Kwok-Kin Wong
    Anil K. Rustgi
    J. Alan Diehl
    Nature Communications, 10
  • [49] YAP inhibition via targeting MAP3K3-dependent lysosomal degradation pathway overcomes BRAF and CDK4/6 inhibitor resistance
    Ryu, Won-Ji
    Park, Sanghyun
    Kim, Tae Yeong
    Hwang, Yumi
    Han, Hyun Ju
    Lee, Jeong Dong
    Kim, Gun Min
    Sohn, Joohyuk
    Kim, Sang Kyum
    Kim, Joon
    Kim, Min Hwan
    CANCER RESEARCH, 2023, 83 (07)
  • [50] Targeting CBX3 with a Dual BET/PLK1 Inhibitor Enhances the Antitumor Efficacy of CDK4/6 Inhibitors in Prostate Cancer
    Liang, Huaiyuan
    Yang, Chunguang
    Zeng, Ruijiang
    Song, Yingqiu
    Wang, Jianxi
    Xiong, Wei
    Yan, Binyuan
    Jin, Xin
    ADVANCED SCIENCE, 2023, 10 (36)
12345